Has Lek Takeover Fallen Through, Delo Wonders
Ljubljana, 20 September - The major Slovenian daily wonders on Friday whether the anticipated takeover of the leading Slovenian pharmaceutical company Lek has fallen through, since the Swiss bidder Novartis insists their price offer is fair, while Lek's two largest shareholders, the state-run funds KAD and SOD, are determined to get more out of the sale.
The rest of this news item is available to subscribers.
The news item consists of 1.260 characters (without spaces) or 248 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.